Barclays PLC increased its stake in Maximus, Inc. (NYSE:MMS – Free Report) by 285.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 170,971 shares of the health services provider’s stock after purchasing an additional 126,573 shares during the quarter. Barclays PLC owned 0.28% of Maximus worth $15,927,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. V Square Quantitative Management LLC acquired a new position in Maximus during the third quarter worth $25,000. Blue Trust Inc. increased its position in shares of Maximus by 201.5% in the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after buying an additional 262 shares in the last quarter. Archer Investment Corp increased its position in shares of Maximus by 8,788.9% in the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock valued at $69,000 after buying an additional 791 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Maximus by 150.6% during the 3rd quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock worth $80,000 after buying an additional 518 shares during the last quarter. Finally, Quarry LP boosted its position in shares of Maximus by 48.0% in the 3rd quarter. Quarry LP now owns 1,017 shares of the health services provider’s stock worth $95,000 after buying an additional 330 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.
Maximus Trading Down 1.3 %
Shares of Maximus stock opened at $69.81 on Monday. Maximus, Inc. has a 1 year low of $69.72 and a 1 year high of $93.97. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49. The business has a 50 day moving average price of $82.58 and a 200 day moving average price of $86.62. The company has a market capitalization of $4.21 billion, a P/E ratio of 13.96 and a beta of 0.73.
Maximus Announces Dividend
Analyst Ratings Changes
Separately, StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a report on Thursday, November 28th.
Get Our Latest Stock Analysis on MMS
Insider Activity
In related news, insider Michelle F. Link sold 1,363 shares of the business’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the transaction, the insider now owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. The trade was a 17.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Raymond B. Ruddy bought 3,490 shares of Maximus stock in a transaction on Thursday, December 12th. The stock was purchased at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the acquisition, the director now owns 112,520 shares in the company, valued at $8,040,679.20. This represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 1.40% of the company’s stock.
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- 3 Small Caps With Big Return Potential
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Industrial Products Stocks Investing
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is a Bond Market Holiday? How to Invest and Trade
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.